SYSTEMATIC FINANCIAL MANAGEMENT LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
SYSTEMATIC FINANCIAL MANAGEMENT LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2020$295,000
-24.2%
3,290
-15.6%
0.02%
-37.5%
Q1 2020$389,000
-32.9%
3,900
-22.8%
0.02%
+4.3%
Q4 2019$580,000
+12.6%
5,050
+23.6%
0.02%0.0%
Q3 2019$515,000
-48.8%
4,085
-51.1%
0.02%
-41.0%
Q2 2019$1,006,000
-23.7%
8,360
-44.5%
0.04%
-13.3%
Q1 2019$1,318,000
+12.0%
15,070
+28.1%
0.04%
+25.0%
Q4 2018$1,177,000
-24.5%
11,760
-13.6%
0.04%
-5.3%
Q3 2018$1,559,000
+9.7%
13,605
-14.2%
0.04%
+8.6%
Q2 2018$1,421,000
-2.8%
15,850
-20.7%
0.04%
+9.4%
Q1 2018$1,462,000
-4.3%
19,980
-24.0%
0.03%
+3.2%
Q4 2017$1,527,000
-3.8%
26,295
-25.6%
0.03%
-3.1%
Q3 2017$1,587,000
-7.6%
35,360
-18.7%
0.03%0.0%
Q2 2017$1,718,000
-4.2%
43,495
-1.6%
0.03%0.0%
Q1 2017$1,793,000
+0.3%
44,190
-0.6%
0.03%
+14.3%
Q4 2016$1,787,000
+5.2%
44,455
-5.2%
0.03%
+16.7%
Q3 2016$1,698,000
-4.1%
46,905
-23.3%
0.02%0.0%
Q2 2016$1,771,000
-26.1%
61,115
-4.6%
0.02%
+33.3%
Q4 2014$2,396,000
+5.9%
64,030
-1.2%
0.02%
+12.5%
Q3 2014$2,262,000
+20.1%
64,800
+21.4%
0.02%
+23.1%
Q2 2014$1,883,000
-1.9%
53,385
-9.3%
0.01%0.0%
Q1 2014$1,919,00058,8900.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders